ANP Technologies, Inc. offers a portfolio of products and services that serve the biodefense, pharmaceutical, life sciences, immunogenicity, and food safety industries.


News and Press Releases

ANP Technologies, in Partnership with Fulgent Pharma, Teams with Moffitt Cancer Center to Develop a New Class of Leukemia Therapies

Add some more info about this item...

ANP Technologies Inc. (ANP) and Fulgent Pharma LLC through their partner Moffitt Cancer Center have successfully licensed the rights to develop a novel targeted therapy in the area of leukemia to Celgene (CELG), now Bristol Myers Squibb (BMY), a landmark deal that leverages ANP’s nanotherapeutic platform technology. The partners will work together to develop a new cancer therapy for Myelodysplastic Syndrome (MDS) and Acute Myeloid Leukemia (AML). The potential new therapy will target a novel pathway receptor.

The U.S. Food and Drug Administration (FDA) has granted approval for ANP Technologies, Inc. and its partner to begin Phase I clinical trials with its first drug – nanoencapsulated paclitaxel.

Add some more info about this item...

What's this item about? What makes it interesting? Write a catchy description to grab your audience's attention...

ANP Technologies® Inc receives Innovators Award from Delaware Bioscience Association

Add some info about this item

Tell people more about this item. What's it about and what makes it interesting? Give people the info they need to go ahead and take the action you want.

To make this item your own, click here > Add & Manage Items.

Please reload

Our Technologies


​​Our NIDS® rapid and handheld assays are widely used by the U.S. military and first responders to detect biological and chemical agent threats.


Using its library of patented polymers, ANP has successfully nanoencapsulated both small and large molecule drugs to improve  pharmacokinetics, reduce toxicity, and enhance therapeutic efficacy, & stability. ANP has multiple drugs at the IND stage or beyond! 


ANP has the best immunogenicity testing products on the market including the renowned ANPEG-1 IgM antibody, comprehensive PEG ELISA Kits, and customizable kits for any application. 

Life Science

We offer a premier portfolio of life science products including ANPEG Antibody, Streptavidin & Neutravidin  ELISA Plates, Protein Labeling & Extraction Kits, Reagents, & more.

Defense/Biological Warfare Customer Feedback 

First-rate Support for Correcting Operational Errors

“ANP’s on-site technical support team is awesome! We ran into some testing problems with the NIDS® multiplexed hand held assays and reader during initial testing. Upon our request, ANP immediately sent their tech support team to our test site and helped us to quickly identify the problem which was caused by insufficient sample volume. After that, there have been no problems what’s so ever. Thank you ANP! We truly appreciate your technical expertise and professionalism!”


Drug Developers

Defense & First Responders

Contract Research Organizations

Academic Institutions


ANP Technologies®, Inc.

824 Interchange Boulevard  Newark, Delaware 19711


  • Black Facebook Icon
  • Black Twitter Icon
  • Black YouTube Icon

Copyright 2020

ANP Technologies®, Inc.